Scientific Advisory Board

Paul A. Granato, Ph.D., DABMM, FAAM

Dr. Granato earned his Ph.D. in microbiology and molecular biology from Syracuse University after graduating from Le Moyne College majoring in biology and chemistry. He then trained in a two-year post-doctoral fellowship program in clinical microbiology and infectious diseases at Columbia University, College of Physicians & Surgeons. Dr. Granato directed several clinical microbiology laboratories over his professional career while serving as a faculty member in the Departments of Pathology and Microbiology & Immunology at SUNY Upstate Medical University for over 35 years where he is now Professor Emeritus in Pathology. He has also served on the Editorial Board of Journal of Clinical Microbiology for 9 years and has been a co-editor for Clinical Microbiology Newsletter for over 30 years. Currently, he directs two consolidated clinical microbiology laboratories in Central New York, five laboratories scattered throughout Florida, as well as being actively involved in various clinical research studies. Dr. Granato is board certified in Clinical Microbiology and Public Health by the American Board of Medical Microbiology, is a Fellow of the American Academy of Microbiology, and is the co-author of two textbooks and over 110 book chapters, scientific articles, and abstracts. Dr. Granato is based in Liverpool, New York.

Richard M. Myers, Ph.D.

Dr. Myers received his BS in biochemistry from the University of Alabama in 1977 and his PhD in biochemistry from the University of California, Berkeley, in 1982. After completing his postdoctoral training at Harvard University, he joined the faculty of the University of California, San Francisco, Medical Center in 1986. He moved to Stanford University in 1993, where he served as professor and chair in the department of genetics. Work in Myers’ Stanford Human Genome Center contributed more than 10 percent of the data for the public Human Genome Project. In 2008 Dr. Myers became President and Science Director of HudsonAlpha Institute for Biotechnology, in Huntsville, Alabama. With 35 years’ experience in genetics and genomics, Dr. Myers leads the Institute, supplying strategic oversight for the research enterprise, including sustaining a large, active laboratory. The Myers Lab studies the genomic and genetic analysis of human traits and diseases to better understand how genomes are involved in cancer, brain disorders, ALS, children born with developmental disorders, autoimmune diseases and other traits. Dr. Myers is also currently an Adjunct Faculty Member, Department of Genetics, with the University of Alabama at Birmingham Medical Center and is a founder of two life sciences start-up companies, Kailos Genetics and IMIDomics.

Fran White

After earning a degree in medical technology, Fran White worked in the clinical microbiology laboratory at New England Deaconess hospital. She worked at Gibco Laboratories for 15 years in a variety of capacities including: Director of Regulatory Affairs, Customer and Technical services, QA Manager, and Customer Service Manager. She Founded MDC Associates, LLC in 1989. Based north of Boston, Massachusetts, MDC Associates is a full-service regulatory affairs and quality assurance consulting company providing a broad range of support services to the in vitro diagnostic and medical device industry. Under her direction and leadership, the company has grown and extended service offerings to include quality systems development, regulatory consulting, managing clinical trials and technical (instead of call center) support. Currently, the company has 40 employees and more than 100 clients. Clients include a wide variety of start-up and well-established companies including Abbott Laboratories and Siemens Diagnostics. In February of 2019, MDC was acquired by a corporation led by Joen T. Johansen formerly of Accelerate Diagnostics. Ms. White will continue to serve as President of Regulatory Affairs.